These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 15032302)

  • 1. Solubilizing excipients in oral and injectable formulations.
    Strickley RG
    Pharm Res; 2004 Feb; 21(2):201-30. PubMed ID: 15032302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of cosurfactants and oils on the formation of pharmaceutical microemulsions based on PEG-8 caprylic/capric glycerides.
    Djekic L; Primorac M
    Int J Pharm; 2008 Mar; 352(1-2):231-9. PubMed ID: 18068919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubilization of cyclosporin A.
    Ran Y; Zhao L; Xu Q; Yalkowsky SH
    AAPS PharmSciTech; 2001 Jan; 2(1):E2. PubMed ID: 14727890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation of parenteral microemulsion containing itraconazole.
    Rhee YS; Park CW; Nam TY; Shin YS; Chi SC; Park ES
    Arch Pharm Res; 2007 Jan; 30(1):114-23. PubMed ID: 17328251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems.
    Cirri M; Mura P; Mora PC
    Int J Pharm; 2007 Aug; 340(1-2):84-91. PubMed ID: 17531411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of cell viability and permeation enhancement in presence of lipid-based self-emulsifying drug delivery systems using Caco-2 cell model: Polysorbate 80 as the surfactant.
    Bu P; Ji Y; Narayanan S; Dalrymple D; Cheng X; Serajuddin AT
    Eur J Pharm Sci; 2017 Mar; 99():350-360. PubMed ID: 28024890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of surfactant/cosurfactant synergism impact on ibuprofen solubilization capacity and drug release characteristics of nonionic microemulsions.
    Djekic L; Primorac M; Filipic S; Agbaba D
    Int J Pharm; 2012 Aug; 433(1-2):25-33. PubMed ID: 22579578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel excipient, 1-perfluorohexyloctane shows limited utility for the oral delivery of poorly water-soluble drugs.
    Holm R; Jørgensen EB; Harborg M; Larsen R; Holm P; Müllertz A; Jacobsen J
    Eur J Pharm Sci; 2011 Mar; 42(4):416-22. PubMed ID: 21256961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of impact of the different hydrophilic carriers on the properties of piperazine-containing drug.
    Ahmed MO
    Eur J Pharm Biopharm; 2001 May; 51(3):221-5. PubMed ID: 11343886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of lipid-based formulations for oral administration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution.
    Mohsin K; Long MA; Pouton CW
    J Pharm Sci; 2009 Oct; 98(10):3582-95. PubMed ID: 19130605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: effects of digestion.
    Mohsin K
    AAPS PharmSciTech; 2012 Jun; 13(2):637-46. PubMed ID: 22547370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclodextrins as functional excipients: methods to enhance complexation efficiency.
    Loftsson T; Brewster ME
    J Pharm Sci; 2012 Sep; 101(9):3019-32. PubMed ID: 22334484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspective on improving passive human intestinal absorption.
    Yalkowsky SH
    J Pharm Sci; 2012 Sep; 101(9):3047-50. PubMed ID: 22374839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of clinical dosage forms for a poorly water-soluble drug II: formulation and characterization of a novel solid microemulsion preconcentrate system for oral delivery of a poorly water-soluble drug.
    Li P; Hynes SR; Haefele TF; Pudipeddi M; Royce AE; Serajuddin AT
    J Pharm Sci; 2009 May; 98(5):1750-64. PubMed ID: 18781639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APPLICATION OF VARIOUS POLYMERS AND POLYMERS BASED TECHNIQUES USED TO IMPROVE SOLUBILITY OF POORLY WATER SOLUBLE DRUGS: A REVIEW.
    Muhammad Sarfraz R; Bashir S; Mahmood A; Ahsan H; Riaz H; Raza H; Rashid Z; Atif Raza S; Asad Abrar M; Abbas K; Yasmeen T
    Acta Pol Pharm; 2017 Mar; 74(2):347-356. PubMed ID: 29624239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies.
    Pouton CW; Porter CJ
    Adv Drug Deliv Rev; 2008 Mar; 60(6):625-37. PubMed ID: 18068260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubilization of flavopiridol by pH control combined with cosolvents, surfactants, or complexants.
    Li P; Tabibi SE; Yalkowsky SH
    J Pharm Sci; 1999 Sep; 88(9):945-7. PubMed ID: 10479359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical optimization of lipid-based dosage forms for the improvement of taste-masking, chemical stability and solubilizing capacity of phenobarbital.
    Monteagudo E; Langenheim M; Salerno C; Buontempo F; Bregni C; Carlucci A
    Drug Dev Ind Pharm; 2014 Jun; 40(6):783-92. PubMed ID: 23607724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-dispersing formulations for the delivery of poorly soluble drugs - Miscibility of phosphatidylcholines with oils and fats.
    Grüne L; Bunjes H
    Eur J Pharm Biopharm; 2020 Jun; 151():209-219. PubMed ID: 32339637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A win-win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeability.
    Miller JM; Beig A; Carr RA; Spence JK; Dahan A
    Mol Pharm; 2012 Jul; 9(7):2009-16. PubMed ID: 22632106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.